Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2024 |
| Reihe/Periodikum: | JTO Clinical and Research Reports ; volume 5, issue 12, page 100745 ; ISSN 2666-3643 |
| Verlag/Hrsg.: |
Elsevier BV
|
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-30414148 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://doi.org/10.1016/j.jtocrr.2024.100745 |
